6 studies were found.

1.		No longer recruiting	A Safety & Effectiveness Study of Intravenous Anidulafungin with AmBisome® for Treatment of Invasive Aspergillosis (IA). Condition: Aspergillosis
2.		Completed	The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients with Invasive Candidiasis. Condition: Candidiasis
3.		No longer recruiting	The Safety and Efficacy of Anidulafungin versus Comparator in Patients with Candidemia and Invasive Candidiasis Condition: Candidiasis
4.		No longer recruiting	Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections Condition: Bacteremia
5.		Completed	The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC) Condition: Candidiasis
6.		Completed	Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17 Condition: Neutropenia